Affimed (AFMD) ROE US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -83.7% | -57.5% | -42.3% | -56.2% | -183.3% | -406.9% | ||
| Changes by years, y/y, % | -35pp | +26pp | +15pp | -14pp | -127pp | +30.4% | |||
Affimed. ROE, %
Affimed. ROE, changes, pp
Affimed (AFMD) ROE US GAAP (quarter values) |
||||||||
| FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | LTM ? | |||
| ROE, % | ? | -160.2% | -183.3% | -229.0% | -275.8% | -406.9% | -406.9% | |
| Changes by years, y/y, % | -121pp | -128pp | -149pp | -163pp | -247pp | |||
| Changes by quarters, q/q, % | -47pp | -23pp | -46pp | -47pp | -131pp | |||